Patent details

EP2330892 Title: METHODS OF TREATMENT USING AMMONIA-SCAVENGING DRUGS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2330892
WO Application Number:
US2009030362
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09739263.3
WO Publication Number:
WO2009134460
EPO Publication Language:
English
SPC Number:
300854
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
07/01/2009
Grant date:
29/06/2016
EP Publication Date:
15/06/2011
WO Publication Date:
05/11/2009
Claims Translations Received Date:
Claims Translation B1 Received Date:
30/08/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
29/06/2016
EP B1 Publication Date:
29/06/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
06/01/2029
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
24/12/2019
 
 

 

Name:
Immedica Pharma AB
Address:
Norrtullsgatan 15, 113 29, Stockholm, Sweden (SE)

Historical Applicant/holder

From:
24/12/2019
To:
24/12/2019

 

Name:
Medical Need Europe AB
Address:
Norrtullsgatan 15, 113 29, Stockholm, Sweden (SE)

From:
25/11/2016
To:
24/12/2019

 

Name:
Horizon Therapeutics, LLC
Address:
150 S. Saunders Rd., 60045, Lake Forest, IL , United States of America (US)

From:
30/08/2016
To:
12/09/2016

 

Name:
Horizon Therapeutics, Inc.
Address:
150 S. Saunders Rd., 60045, Lake Forest, IL , United States of America (US)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
30/08/2016
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

Name:
SCHARSCHMIDT, Bruce
Address:
South San Francisco, CA 94080, United States of America (US)

Priority

Priority Patent Number:
93234
Priority Date:
29/08/2008
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
G01N 33/68;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
53/19
Publication date:
01/01/2020
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
53/19
Publication date:
01/01/2020
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
42/16
Publication date:
19/10/2016
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
EP3
Journal edition number:
36/16
Publication date:
07/09/2016
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:
EP2
Journal edition number:
26/16
Publication date:
29/06/2016
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201631
Publication date:
03/08/2016
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201626
Publication date:
29/06/2016
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201902630A
Date Registered:
24/12/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Medical Need Europe AB
Address:
Norrtullsgatan 15, 113 29, Stockholm, Sweden (SE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201902630B
Date Registered:
24/12/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Immedica Pharma AB
Address:
Norrtullsgatan 15, 113 29, Stockholm, Sweden (SE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC201602256A
Date Registered:
12/09/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
J.M.H. Duyver lic.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Horizon Therapeutics, LLC
Address:
2000 Sierra Point Parkway Suite 400, Brisbane, CA 94005, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC201602179A
Date Registered:
30/08/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Other

Note:

Annual Fee

Annual Fee(s) Due Date:
31/01/2026
Annual Fee Number:
18
Annual Fee Amount:
1200 Euro
Last Annual Payment Date:
19/11/2024
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
1100 Euro
Payer:
Zacco Sweden AB Patent Department
Filing date Document type Document Description Number of pages File Type
14/10/2016 Outgoing Correspondence Letter registration deed 1 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_3_90503l118.pdf
07/10/2016 Outgoing Correspondence Letter registration deed 1 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_6_88847l118.pdf
12/09/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_4_incomingcorrespondencepaper20161011025511160.pdf
12/09/2016 Request for Change First filed deed 2 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_8_rfc20161011025511256.pdf
02/09/2016 Outgoing Correspondence Letter no formal defects 1 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_1_80372l271.pdf
30/08/2016 Request for Change First filed deed 2 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_0_rfc20160929042111023.pdf
30/08/2016 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_2_incomingcorrespondencepaper20160929042110931.pdf
30/08/2016 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_5_incomingcorrespondenceelectronic20160830161321305.pdf
30/08/2016 Claims First filed claims 4 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_7_claims20160830161320394.pdf
30/08/2016 Incoming Correspondence Electronic EOB model 2 PDF /5/3/8/6/6/0800066835/docs/ep09739263.3_9_incomingcorrespondenceelectronic20160830161319294.pdf